Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
M. Tsuboi, R. Herbst, T. John, T. Kato, M. Majem, C. Grohé, Jie Wang, J. Goldman, Shun Lu, W. Su, F. de Marinis, F. Shepherd, K. Lee, N. Le, A. Dechaphunkul, D. Kowalski, L. Poole, Ana Bolanos, Y. Rukazenkov, Yi‐Long Wu
New England Journal of Medicine